Reach out for a recording of CaliberMRI’s April user group session!
We are were pleased to have had Drs. Sigmund and Basukala present at our user goup session on April 7th! If you missed the session, reach out to us directly for the recording!

Warm regards,

The CaliberMRI Team

Topic:  Multisite MRI Intravoxel Incoherent Motion Repeatability and Reproducibility across 3 T Scanners in a Breast Diffusion Phantom: A BReast Intravoxel Incoherent Motion Multisite (BRIMM) Study

Overview:

Monoexponential apparent diffusion coefficient (ADC) and biexponential intravoxel incoherent motion (IVIM) analysis of diffusion-weighted imaging (DWI) is helpful in the characterization of breast tumors. However, repeatability and reproducibility studies across scanners and across sites are scarce. Therefore, the purpose of this study is to evaluate the repeatability and reproducibility of ADC and IVIM parameters (tissue diffusivity (Dt), perfusion fraction (fp) and pseudo-diffusion (Dp)) within and across sites employing MRI scanners from different vendors in a customized breast diffusion phantom (built in collaboration with CaliberMRI). The studies were performed twice in each of two scanners (different vendors and institutions), on each of 2 days, resulting in four studies per scanner. A bipolar gradient twice-refocused spin echo sequence and monopolar gradient single spin echo sequence at 3 T were used in the two scanners. ADCs of the polyvinylpyrrolidone (PVP) and water were compared with the vendor-calibrated values at the temperature indicated by the in situ liquid crystal thermometer.

ADC and IVIM repeatability and reproducibility within and across sites were estimated via the within-system coefficient of variation (wCV). Pearson correlation coefficient (r) was also computed between IVIM metrics and flow speed. ADC and Dt demonstrated excellent repeatability and reproducibility at the two sites. fp and Dp exhibited good and moderate reproducibility. fp and Dt demonstrated high correlations with flow speed while Dp showed lower correlations. fp correlations with flow speed were significant at both sites. IVIM results were reproducible within both sites, and a progressive trend towards reproducibility across sites except for fp, which may have been impacted by different gradient waveforms.

Presenters:

Dr. Eric Sigmund is a Professor in the Department of Radiology at NYU Grossman School of Medicine. Prof. Sigmund’s group actively researches advanced diffusion MRI applications throughout the body, including intravoxel incoherent motion (IVIM), diffusion tensor imaging (DTI), and diffusion kurtosis imaging (DKI) in a range of applications (especially oncologic imaging in breast and kidney, renal function).

Dr. Basukala is a postdoctoral fellow in the Department of Radiology at NYU Grossman School of Medicine working with Dr. Sigmund. He has worked on evaluation and translation of intravoxel incoherent motion (IVIM) for characterization of breast cancer malignancy and prediction of treatment response. He has experience in biomedical imaging, phantoms and retrospective multicenter and multivendor breast cancer studies using multiple software platforms including deep learning.

Recent papers by Drs. Sigmund and Basukala

Multisite MRI Intravoxel Incoherent Motion Repeatability and Reproducibility across 3 T Scanners in a Breast Diffusion Phantom: A BReast Intravoxel Incoherent Motion Multisite (BRIMM) Study

Motion and Flow Robust Free-Breathing Diffusion Kurtosis Imaging of the Kidney

Evaluating Breast Cancer Intravoxel Incoherent Motion MRI Biomarkers across Software Platform

Cardiac gated diffusion-weighted MR imaging assessment of kidney function in kidney cancer patients

Related Articles

November 18th – User Group Session | Traumatic Brain Injury, the TRACK-TBI Study, Data, and Quantitative Imaging | Dr. Pratik Mukherjee (UCSF)

Topic: Traumatic Brain Injury, the TRACK-TBI Study, Data, and Quantitative Imaging
Guest Speaker:  Dr. Pratik Mukherjee MD, PhD, UCSF

Dr. Mukherjee is a Professor in Residence in the Department Radiology and Biomedical Imaging, Bioengineering, and he is an attending neuroradiologist at the University of California, San Francisco. He is the Director of the Center for Imaging of Neurodegenerative Disease (CIND) based at the San Francisco VA Medical Center. He also directs the Neural Connectivity Laboratory (NCL) at UCSF China Basin.

 Dr. Mukherjee’s primary clinical research is the study of neurodevelopmental disorders and traumatic brain injury (TBI) using advanced neuroimaging and artificial intelligence/machine learning (AI/ML) technology. His research has been focused on technical development, neuroscience and clinical applications of advanced imaging methods for mapping structure and function of the human brain, especially diffusion MRI, which is a popular technique for assessing the development and integrity of white matter and for mapping axonal fiber pathways.
 Scope:  Dr. Mukherjee will discuss his work on traumatic brain injury with the TRACK-TBI trial and on advanced neuroimaging and artificial intelligence/machine learning (AI/ML) technology.

Article Word Cloud!

Take a look at our word cloud: qMRI, imaging, diffusion, T1, T2 ADC Mapping! Reproduciblity! QA/QC! Repeatability, Reproducibility, QA/QC!

2025 User Group Session Calendar!

We are excited to share our 2025 User Group Sessions!  Mark your calendars: SESSION 1: Tuesday, April 1st, 9:00 a.m. MDT Topic: Annual Physics Testing with the CaliberMRI Mini Hybrid Phantom. Guest Speaker: Norman P. Sipp, MS DABR, Chief Diagnostic Medical Physicist: Ascension Seton Network-Austin, TX SESSION 2: Tuesday, June 24th, 9:00 a.m. MDT Topic: […]

CaliberMRI announces release of the qDisc, a new quantitative MRI phantom for added functionality of the Medium ACR Phantom

BOULDER, Colo., Nov. 26, 2025 /PRNewswire/ — CaliberMRI, an industry leader in standardizing Magnetic Resonance Imaging (MRI), announced the release of a new quantitative MRI phantom compatible with the Medium ACR phantom. CaliberMRI’s qDisc (quantitative Dual Imaging Standardization Compartment) Model 141 allows sites to baseline T1, T2, ADC, and Proton Density in a single slice when scanning the Medium ACR phantom. The qDisc includes the Company’s patented MR readable LC Thermometer and is supported by qCal-MR®, an automated QA/QC analysis software. “This offering provides a practical option for gathering important quantitative metrics during routine scans with an ACR phantom,” says William Hollander, CEO of CaliberMRI. “With the rise of quantitative MRI offerings, the qDisc can be used as a first step toward harmonization of MRI scanners and AI software for analysis”. Hollander added. This phantom is intended to complement CaliberMRI’s more complete phantom platform solutions.

2025 – a year in review – 60 papers and hundreds of authors advancing qMRI

Looking back to 2025, we want to thank the hundreds of customers and collaborators who authored more than 60 papers, talks, and abstracts using CaliberMRI phantoms. Products cited include: (1) Relaxometry phantoms (T1, T2, PD) – National Institute of Standards and Technology (NIST)/ISMRM Model 130 (as well as Models 136 and 106) (2) Diffusion phantom […]

CaliberMRI User Group Session 2 – June – The variability of Mean ADC Measurements with Simultaneous Multi-slice Imaging in a NIST/QIBA/CaliberMRI Diffusion Phantom

Join us for Session 2:  Tuesday, June 24th, 9:00 AM (MDT).  To sign up or for login details, please email info[at]qmri.com.
Topic: The variability of Mean ADC Measurements with Simultaneous Multi-slice Imaging in a NIST/QIBA/CaliberMRI Diffusion Phantom
Guest Speakers: Dr. Ryckie Wade, PhD, and Matthew Marzetti, MsC, University of Leeds, United Kingdom

APS Session – Multiparametric Tissue Mimics for Breast Imaging and Medical Device Testing

Multiparametric Tissue Mimics for Breast Imaging and Medical Device Testing
Stephen Russek, Todor Karaulanov (presenter), Willaim Hollander, Chamni Jayarathna, Callie Weiant, John Wenzel, Shannon John

We present our work on developing anatomically realistic, quantitative multiparametric MRI (qMRI) phantoms designed to standardize imaging of both healthy and diseased breast tissue. The lack of standardized, morphology-accurate phantoms currently limits the effectiveness of qMRI in both clinical and research settings. Without realistic tissue-mimicking models, radiologists, technologists, and researchers face challenges in learning optimal acquisition protocols and interpreting quantitative data.

Great Reading For ASTRO!

Are you heading to ASTRO next week?  If so, take a look at some incredible articles below (some hot off the press!).  Please reach out directly to authors on their work or to CaliberMRI on our phantoms.  If you’d like to set up a meeting at ASTRO, please reach out to us directly at info@qmri.com. […]

Join Us at RSNA – Booth 7610 – North Hall Level 3

Heading to RSNA?  We’ll be exhibiting at Booth 7610 (North Hall Level 3) and would love to discuss QA/QC, AI/ML/DL testing and validation, R&D, and/or custom solutions.  Our cloud-based software, qCal-MR, now supports more than 45 scanner makes and models on Canon, GEHC, Hyperfine, Philips, Siemens, and United Imaging Scanners.  We’ll be showcasing our new products, and are available to discuss collaborations.  Reach out if you’d like to set up a meeting.

Open Office Hours – Every Tuesday 9-10 a.m. MDT!

Join us for open office hours! Ask questions about your phantom, qCal-MR and meet others advancing quantitative MRI!

CaliberMRI receives grant for work in Africa and Southeast Asia

Quantitative MRI technology developer CaliberMRI has received a grant from the Bill & Melinda Gates Foundation to help standardize portable MRI imaging for neonatal and pediatric brain development of children in Africa and Southeast Asia.

Federation of American Scientists (FAS) DAY ONE PROGRAM – A Quantitative Imaging Infrastructure to Revolutionize AI-Enabled Precision Medicine

Medical imaging, a non-invasive method to detect and characterize disease, stands at a crossroads. With the explosive growth of artificial intelligence (AI), medical imaging offers extraordinary potential for precision medicine yet lacks adequate quality standards to safely and effectively fulfill the promise of AI. Now is the time to create a quantitative imaging (QI) infrastructure to drive the development of precise, data-driven solutions that enhance patient care, reduce costs, and unlock the full potential of AI in modern medicine.